University of Pennsylvania - Center for Advanced Retinal & Ocular Therapeutics — Philadelphia, Pennsylvania

University of Pennsylvania - Center for Advanced Retinal & Ocular Therapeutics is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Pennsylvania - Center for Advanced Retinal & Ocular Therapeutics has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis.

Sponsors: Laboratoires Thea.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pennsylvania - Center for Advanced Retinal & Ocular Therapeutics?

University of Pennsylvania - Center for Advanced Retinal & Ocular Therapeutics has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pennsylvania - Center for Advanced Retinal & Ocular Therapeutics conducted?

University of Pennsylvania - Center for Advanced Retinal & Ocular Therapeutics has 1 clinical trials on record, with 1 currently active. Their work covers Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis.

Is University of Pennsylvania - Center for Advanced Retinal & Ocular Therapeutics accredited by Crixeo Health?

University of Pennsylvania - Center for Advanced Retinal & Ocular Therapeutics has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pennsylvania - Center for Advanced Retinal & Ocular Therapeutics?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.